Kim Ellison
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 10
- Lung Cancer Research Studies 6
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 1
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Christopher J. Rivard (15 shared papers)Leslie M. Rozeboom (10 shared papers)Hui Yu (9 shared papers)Yayi He (4 shared papers)Fred R. Hirsch (7 shared papers)Rafal Dziadziuszko (6 shared papers)Kenichi Suda (10 shared papers)Fred R. Hirsch (9 shared papers)
- Journals
- Journal of Thoracic Oncology (5 papers)Lung Cancer (3 papers)Journal of Biological Chemistry (2 papers)PLoS ONE (1 paper)Cancer Science (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Kim Ellison
22 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Oncology 707
- Immunology 300
- Cancer Research 137
- Pulmonary and Respiratory Medicine 206
- Molecular Biology 421
Countries citing papers authored by Kim Ellison
This map shows the geographic impact of Kim Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Ellison more than expected).
Fields of papers citing papers by Kim Ellison
This network shows the impact of papers produced by Kim Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Ellison. The network helps show where Kim Ellison may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim Ellison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 229 | |
| 2 | 2016 | 160 | |
| 3 | 1989 | 119 | |
| 4 | 2016 | 117 | |
| 5 | 2017 | 98 | |
| 6 | 1992 | 73 | |
| 7 | 2017 | 55 | |
| 8 | 2018 | 43 | |
| 9 | 2020 | 42 | |
| 10 | 2018 | 40 | |
| 11 | 2018 | 40 | |
| 12 | 1996 | 37 | |
| 13 | 1991 | 32 | |
| 14 | 2015 | 32 | |
| 15 | 2017 | 26 | |
| 16 | 2018 | 24 | |
| 17 | 2022 | 24 | |
| 18 | 2017 | 20 | |
| 19 | 2017 | 14 | |
| 20 | 2016 | 12 |
About Kim Ellison
Kim Ellison is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Biological Psychiatry and Virology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (2 papers), DNA Repair Mechanisms (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Cancer Mechanisms and Therapy (1 paper) and Poxvirus research and outbreaks (1 paper). The work is most often cited by research in Oncology (707 citations), Immunology (300 citations), Cancer Research (137 citations), Pulmonary and Respiratory Medicine (206 citations) and Molecular Biology (421 citations). Kim Ellison has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Christopher J. Rivard, Leslie M. Rozeboom, Hui Yu, Yayi He, Fred R. Hirsch, Rafal Dziadziuszko, Kenichi Suda, Fred R. Hirsch, Michael J. Ellison and Caicun Zhou. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Journal of Biological Chemistry, PLoS ONE and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.